Prostate Cancer
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
October 3, 2023
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system.
October 2, 2023
Oncological and functional results of focal treatment of localized prostate cancer with HIFU.
October 2, 2023
Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers.
October 2, 2023
T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence.
September 29, 2023
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer.
September 29, 2023
MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation.
September 29, 2023
Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer.
September 29, 2023
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer.
September 28, 2023
The utility of [18F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate Resistant Prostate Cancer Patients (nmCRPCp): Diagnostic performance and Impact on Management.
September 28, 2023
Association Between Urologist Merit-based Incentive Payment System Performance and Quality of Prostate Cancer Care.
September 28, 2023